Stock Groups

U.S. ready to roll out boosters pending FDA, CDC approval

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO: United States Surgeon General Vivek Murthy delivers remarks during a news conference with White House Press Secretary Jen Psaki at the White House in Washington, U.S., July  15, 2021. REUTERS/Tom Brenner

WASHINGTON (Reuters) – The United States is ready to roll out COVID-19 vaccine booster shots once the Federal Drugs Administration and the Centers for Disease Control and Prevention approve the plan, Surgeon General Vivek Murthy said on Friday.

Murthy stated that once the FDA’s and CDC have completed their evaluations, they will allow us to proceed accordingly.

Rochelle Wilensky, CDC Director, said that $2.1 billion will be invested by the CDC to safeguard patients and workers from future infections.

Jeff Zients (White House coronavirus respond coordinator) said that 89% have been vaccinated against COVID-19 so far.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are generated by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]